Shire PLC Stock price Nasdaq

Equities

SHPG

US82481R1068

Pharmaceuticals

Delayed Nasdaq 5-day change 1st Jan Change
- USD -.--% Intraday chart for Shire PLC +3.58% +2.96%
Dynamic Chart
Managers TitleAgeSince
Director/Board Member - 19-01-07
Corporate Officer/Principal - -
Human Resources Officer - 12-03-31
Members of the board TitleAgeSince
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
More insiders
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
More about the company
  1. Stock
  2. Equities
  3. Stock Shire
  4. Stock Shire PLC - Nasdaq